Leader in robotic surgery with the system. Analysts highlight its large competitive moat and the acceleration of robotic-assisted procedures worldwide. Danaher Corp. (DHR)
Remains a "Strong Buy" pick for 2026, recognized by William Blair for its vital role in global lab research and diagnostic infrastructure. High-Growth Healthcare Stocks in India
Successfully navigating the patent expiration of by scaling its next-generation immunology drugs, Skyrizi and Rinvoq . Thermo Fisher Scientific (TMO)
: Obesity treatments are now considered "strategic investments" rather than just medications, as they reduce long-term cardiovascular risks and overall healthcare costs.